Clinical Trials
3 trialsNCT02723006 2024-03-05
Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of Investigational Treatments in Combination With Standard of Care Immune Checkpoint Inhibitors in Participants With Advanced Melanoma
Takeda
Phase 1 Terminated
NCT02768532 2023-06-15
VEDO-PREDIRESP
Centre Hospitalier Universitaire de Saint Etienne
Phase 4 Terminated
NCT03802214 2020-12-21
Ulcerative Colitis - Vedolizumab- With/Without Prior Exposure to Anti-TNF（Tumor Necrosis Factor）Therapy
Stanford University
Terminated